Saying cannabis kills cancer is in fact wrong, it implies smoking cannabis will kill cancer and that is not correct. It must be ingested in high doses of cannabinoids such as the Rick Simpson Oil or juiced from fresh raw cannabis. The correct way to discuss it is to say that cannabinoids kill cancer. Scientific studies continue to prove that regularly. 1 Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells. ncbi.nlm.nih.gov/pubmed/18025276 2 The endocannabinoid system in prostate cancer. ncbi.nlm.nih.gov/pubmed/21912423 3 Targeting cannabinoid receptors to treat leukemia: role of cross-talk between extrinsic and intrinsic pathways in Delta9-tetrahydrocannabinol (THC)- induced apoptosis of Jurkat cells. ncbi.nlm.nih.gov/ pubmed/15978942 4 The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas. ncbi.nlm.nih.gov/pubmed/20090845 5 In vivo effects of cannabinoids on macromolecular biosynthesis in Lewis lung carcinomas. ncbi.nlm.nih.gov/pubmed/616322 6 Cannabinoid receptor as a novel target for the treatment of prostate cancer. ncbi.nlm.nih.gov/pubmed/15753356 7 Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. ncbi.nlm.nih.gov/ pubmed/12091357 8 Cannabinoids for cancer treatment: progress and promise. ncbi.nlm.nih.gov/pubmed/18199524 Full Text - ncbi.nlm.nih.gov/pubmed/ 18199524 9 Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. ncbi.nlm.nih.gov/pubmed/19457575 Full Article - sciencedirect/science/article/pii/S0171298509000709 10 Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria. ncbi.nlm.nih.gov/pubmed/16908594 Full article - mcr.aacrjournals.org/content/4/8/549.long 11 Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo. ncbi.nlm.nih.gov/ pubmed/12130702 jpet.aspetjournals.org/content/302/2/451.long 12 Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival. ncbi.nlm.nih.gov/pubmed/20053780 13 Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression. ncbi.nlm.nih.gov/pubmed/16754784 14 The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas. ncbi.nlm.nih.gov/pubmed/20090845 15 Cannabinoid receptor systems: therapeutic targets for tumour intervention. ncbi.nlm.nih.gov/pubmed/14640910 16 The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K- AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells. ncbi.nlm.nih.gov/pubmed/17583570 17 Cannabinoids and cell fate. ncbi.nlm.nih.gov/pubmed/12182964 Full Text - sciencedirect/ science/article/pii/S0163725802002565 18 Cannabinoid receptor systems: therapeutic targets for tumour intervention. ncbi.nlm.nih.gov/pubmed/14640910 19 Antineoplastic and apoptotic effects of cannabinoids. N-acylethanolamines: protectors or killers? ncbi.nlm.nih.gov/pubmed/18438336 20 The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration. ncbi.nlm.nih.gov/pubmed/19916793 21. A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells. ncbi.nlm.nih.gov/pubmed/18387516 Full text - sciencedirect/science/ article/pii/S1567576908000234 22 Cannabinoid receptors as novel targets for the treatment of melanoma. ncbi.nlm.nih.gov/pubmed/17065222 full text - fasebj.org/content/20/14/2633.long 23 p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells. ncbi.nlm.nih.gov/pubmed/16139274 24 Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. ncbi.nlm.nih.gov/ pubmed/12511587 full text - ncbi.nlm.nih.gov/pmc/articles/PMC151833/ 25 Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation. ncbi.nlm.nih.gov/pubmed/16818634 26 Cannabidiol: The Wonder Drug of the 21st Century? ukcia.org/research/ cbd.php hightimes/read/5-pro-pot-myths-must-be-busted
Posted on: Fri, 27 Sep 2013 18:46:58 +0000
Trending Topics
Recently Viewed Topics
© 2015